BPX-601
BP-012
Phase 1 mab terminated
Quick answer
BPX-601 for Metastatic Castration-resistant Prostate Cancer is a Phase 1 program (mab) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated